This meeting is for UK healthcare professionals only

Agenda
18:55 Registration
19:00 Welcome & Introduction Dr Shazia Azizuddin, Regional Medical Advisor, Novo Nordisk
19:05 Formulary Update and guidance for GLP-1 RA's Dr Adrian Park, Consultant, Addenbrookes
19:10 Highlights from the American Diabetes Association (ADA) 2021 Dr Adrian Park
19:45 Rybelsus®▼ (Semaglutide Tablets) The Worlds First oral GLP-1 RA: How does it work? Dr Craig Parkinson, Consultant, Ipswich
20:20 Discussion Dr Adrian Park and Dr Craig Parkinson.
20:30 Meeting Close

MS Teams link in email.

Interested in attending this meeting? RSVP to:

Karen Shannon, Senior Diabetes Account Specialist
KSZY@novonordisk.com
07901 536470

Please respond by Wednesday 13th October 2021

This meeting is organised and funded by Novo Nordisk.